Quasar Medical has announced a definitive agreement with Nordson Corporation to acquire its design and development contract manufacturing businesses located in Galway, Ireland, and Tecate, Mexico. This acquisition aims to bolster Quasar's position as a global leader in the manufacturing of interventional and minimally invasive devices by integrating these facilities into its expanding global platform. The Galway and Tecate sites will enhance Quasar's capabilities in complex balloon and catheter design, rapid prototyping, and cost-effective device assembly. The deal is expected to be finalized in the third quarter of 2025, marking a significant expansion for Quasar Medical's full-lifecycle CDMO platform.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。